South Korea Real-Time PCR qPCR Market Size, Share, and COVID-19 Impact Analysis, By Product (Reagents Consumables, Instruments, and Software Services), By Application (Clinical, Research, and Forensics), and South Korea Real-Time PCR qPCR Market Insights, Industry Trend, Forecasts to 2035

South Korea Real-Time PCR qPCR Market Insights Forecasts to 2035

• The South Korea Real-Time PCR qPCR Market Size was Estimated at USD 95.8 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 6.15% from 2025 to 2035
• The South Korea Real-Time PCR qPCR Market Size is Expected to Reach USD 184.8 Million by 2035

According to a Research Report Published by Spherical Insights & Consulting, the South Korea Real-Time PCR qPCR Market Size is Anticipated to Reach USD 184.8 Million by 2035, Growing at a CAGR of 6.15% from 2025 to 2035. The increasing prevalence of infectious diseases and the need for quick, precise clinical diagnostics. Adoption in hospitals, research labs, and forensic applications is further accelerated by developments in molecular technologies, greater investment in personalized medicine, and government support for healthcare innovation.

Market Overview

The South Korea real-time PCR (qPCR) market refers to the domestic ecosystem for quantitative polymerase chain reaction technologies, which allow for accurate amplification and real-time detection of DNA/RNA sequences, is referred to as the South Korean real-time PCR (qPCR) market. Additionally, opportunities exist for stakeholders in the South Korean qPCR market to innovate and create new applications, especially in the domains of personalized medicine and agricultural biotechnology. The increasing investment in research and development by the public and private sectors points to a strong commitment to improving health outcomes through advanced diagnostic technologies. Furthermore, cooperation between academic institutions and industry players can lead to the creation of novel products that are customized to the particular needs of the South Korean market. Automation of qPCR processes has become more popular recently as a way to increase productivity and reduce human error. This trend toward automation is being aided by the South Korean government's support for the digitization of healthcare and the incorporation of AI into diagnostics.

Report Coverage

This research report categorizes the market for the South Korea real-time PCR qPCR market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea real-time PCR qPCR market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the South Korea real-time PCR qPCR market.

Driving Factors

Rapid technological advancements in qPCR systems are driving the South Korean real-time PCR qPCR market. The market has seen increasing adoption in both clinical and research settings thanks to innovations like multiplex qPCR, which can detect multiple targets at once. Recent developments show that the use of AI and machine learning in qPCR analysis has improved diagnostic capabilities by increasing efficiency and accuracy. This innovation is being driven by South Korea's thriving biotechnology sector, which is backed by many universities and research institutions. The outcome is a competitive market environment that encourages the development of cutting-edge qPCR technologies. For instance, Seoul National University has released qPCR technology developments that show notable gains in sensitivity and specificity, supporting the region's overall market expansion.

Restraining Factors

The real-time PCR qPCR market in South Korea is constrained by high equipment costs, restricted reimbursement, and complicated regulations. Furthermore, despite growing demand for automation and molecular diagnostics, wider adoption is hampered by a lack of skilled labor, data privacy issues, and sluggish adoption in smaller labs.

Market Segmentation

The South Korea real-time PCR qPCR market share is classified into product and application.

• The reagents consumables segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea real-time PCR qPCR market is segmented by product into reagents consumables, instruments, and software services. Among these, the reagents consumables segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. Consumable reagents are essential because they have a direct impact on the precision and effectiveness of PCR reactions, highlighting research and development efforts to improve these materials' performance.

• The clinical segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea real-time PCR qPCR market is segmented by application into clinical, research, and forensic. Among these, the clinical segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. Disease diagnosis and monitoring are highly valued in the clinical setting, thanks to developments in molecular biology that improve the precision and speed of pathogen identification.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea real-time PCR qPCR market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Seegene Inc.
• Thermo Fisher Scientific Korea
• Roche Diagnostics Korea
• Bio-Rad Laboratories Korea
• Qiagen Korea
• Others

Recent Developments:

• In September 2024, Seegene Inc. had launched Novaplex Mpox PCR test assays in late 2024 for research use, targeting Orthopoxvirus strains including Clades 1 and 2 of the Mpox virus. These assays utilized multiplex PCR technology for simultaneous detection and early differentiation, addressing rising mpox cases

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea Real-Time PCR qPCR Market based on the below-mentioned segments:

South Korea Real-Time PCR qPCR Market, By Product

• Reagents Consumables
• Instruments
• Software Services

South Korea Real-Time PCR qPCR Market, By Application

• Clinical
• Research
• Forensics